The following three posters were presented to the participants:
- Horses vaccinated with Strangvac did not develop clinical signs of disease, despite serological evidence that they had been exposed to S.equi. This is a collaboration between SVA, KI, SLU,
Intervacc , and Mybac-Vettech. -
Vaccination with Strangvac was immunogenic and caused transient side effects in horses. A collaboration between KI, the National Equestrian Centres, SVA,
Intervacc , and Mybac-Vettech. -
Sequencing the S.equi genome highlighted that screening, quarantine and vaccination are likely to have the greatest impact in preventing strangles. A collaboration between the
Royal Veterinary College , theUniversity of Cambridge ,Intervacc , Surveillance of Equine Strangles, and EIDS.
"Horses all over the world are affected by strangles and it is extremely important to communicate these findings from
For more information please contact:
E-mail: jonas.sohlman@intervacc.se
Phone: +46 (0)8 120 10 600
The information was submitted for publication, through the agency of the contact person set out above on
About equine strangles
Strangles, caused by the bacterium Streptococcus equi, is a severe, common and highly contagious infectious disease that can kill up to 10% of horses. Strangles is endemic in horse populations worldwide, with the exception of
About
Contact information for Certified Adviser
E-mail: adviser@eminova.se, Phone: +46 (0)8 - 684 211 10
https://news.cision.com/intervacc/r/intervacc-has-presented-new-findings-at-the-acvim-forum-in-the-united-states,c4000317
https://mb.cision.com/Main/4632/4000317/2862579.pdf
https://news.cision.com/intervacc/i/intervacc-sm-en,c3310022
(c) 2024 Cision. All rights reserved., source